107 related articles for article (PubMed ID: 7582256)
21. Secreted type of modified interleukin-18 gene transduced into mouse renal cell carcinoma cells induces systemic tumor immunity.
Hara S; Nagai H; Miyake H; Yamanaka K; Arakawa S; Ichihashi M; Kamidono S; Hara I
J Urol; 2001 Jun; 165(6 Pt 1):2039-43. PubMed ID: 11371924
[TBL] [Abstract][Full Text] [Related]
22. Transduction of human melanoma cells with interleukin-2 gene reduces tumorigenicity and enhances host antitumor immunity: a nude mouse model.
Abdel-Wahab Z; Li WP; Osanto S; Darrow TL; Hessling J; Vervaert CE; Burrascano M; Barber J; Seigler HF
Cell Immunol; 1994 Nov; 159(1):26-39. PubMed ID: 7954840
[TBL] [Abstract][Full Text] [Related]
23. In vitro and in vivo characteristics of human squamous cell carcinoma of the head and neck cells engineered to secrete interleukin-2.
Nagashima S; Reichert TE; Kashii Y; Suminami Y; Chikamatsu K; Whiteside TL
Cancer Gene Ther; 1997; 4(6):366-76. PubMed ID: 9408607
[TBL] [Abstract][Full Text] [Related]
24. Inoculation of human interleukin-17 gene-transfected Meth-A fibrosarcoma cells induces T cell-dependent tumor-specific immunity in mice.
Hirahara N; Nio Y; Sasaki S; Minari Y; Takamura M; Iguchi C; Dong M; Yamasawa K; Tamura K
Oncology; 2001; 61(1):79-89. PubMed ID: 11474253
[TBL] [Abstract][Full Text] [Related]
25. Combination of transforming growth factor beta antisense and interleukin-2 gene therapy in the murine ovarian teratoma model.
Dorigo O; Shawler DL; Royston I; Sobol RE; Berek JS; Fakhrai H
Gynecol Oncol; 1998 Nov; 71(2):204-10. PubMed ID: 9826461
[TBL] [Abstract][Full Text] [Related]
26. Human renal carcinoma line transfected with interleukin-2 and/or interferon alpha gene(s): implications for live cancer vaccines.
Belldegrun A; Tso CL; Sakata T; Duckett T; Brunda MJ; Barsky SH; Chai J; Kaboo R; Lavey RS; McBride WH
J Natl Cancer Inst; 1993 Feb; 85(3):207-16. PubMed ID: 8423625
[TBL] [Abstract][Full Text] [Related]
27. Rapid adenoviral transduction of freshly resected tumour explants with therapeutically useful genes provides a rationale for genetic immunotherapy for colorectal cancer.
Diaz RM; Todryk S; Chong H; Hart IR; Sikora K; Dorudi S; Vile RG
Gene Ther; 1998 Jul; 5(7):869-79. PubMed ID: 9813657
[TBL] [Abstract][Full Text] [Related]
28. Accelerated recovery of irradiation-induced bone marrow depression by fibroblast-mediated interleukin 6 gene therapy in combination with bone marrow transplantation in mice.
Cao X; Cai R; Ju DW; Tao Q; Yu Y; Wang J
Transplantation; 1998 Feb; 65(3):325-31. PubMed ID: 9484747
[TBL] [Abstract][Full Text] [Related]
29. Adjuvant effect of a Flt3 ligand (FL) gene-transduced xenogeneic cell line in a murine colon cancer model.
Kim EM; Sivanandham M; Stavropoulos CI; Wallack MK
J Surg Res; 2002 Nov; 108(1):148-56. PubMed ID: 12443727
[TBL] [Abstract][Full Text] [Related]
30. Anti-tumor effect of murine renal cell carcinoma cells genetically modified to express B7-1 combined with cytokine secreting fibroblasts.
Wang J; Nakamoto T; Kasaoka Y; Usui T; Hamada H
Hiroshima J Med Sci; 2000 Mar; 49(1):73-82. PubMed ID: 10824460
[TBL] [Abstract][Full Text] [Related]
31. [Enhanced immune functions and antitumor activity of fibroblast-mediated interleukin-2 gene therapy].
Cao XT; Zhang WP; Tao Q
Zhonghua Yi Xue Za Zhi; 1995 Sep; 75(9):521-4, 573. PubMed ID: 8556540
[TBL] [Abstract][Full Text] [Related]
32. Development and characterization of an interleukin-2-transduced human ovarian carcinoma tumor vaccine not expressing major histocompatibility complex molecules.
Santin AD; Ioli GR; Hiserodt JC; Manetta A; Pecorelli S; DiSaia PJ; Granger GA
Am J Obstet Gynecol; 1996 Feb; 174(2):633-40. PubMed ID: 8623798
[TBL] [Abstract][Full Text] [Related]
33. [Study of the therapeutic effects of costimulatory molecules B7-1 and interleukin 12 modified tumor cells vaccines on ovarian epithelial carcinoma through induction of anti-cancer immunity of the body].
Liang HM; Jiang J; Kong BH; Ma DX; Jiang S
Zhonghua Fu Chan Ke Za Zhi; 2003 Jun; 38(6):354-8. PubMed ID: 12895379
[TBL] [Abstract][Full Text] [Related]
34. Retroviral-mediated IL-2 gene transfer into murine neuroblastoma.
Cho HS; Song JY; Park CY; Lyu CJ; Kim BS; Kim KY
Yonsei Med J; 2000 Feb; 41(1):76-81. PubMed ID: 10731923
[TBL] [Abstract][Full Text] [Related]
35. Interleukin-2-mediated modulation of plasma cell tumor growth in a model of multiple myeloma.
Kopantzev E; Roschke V; Rudikoff S
Hum Gene Ther; 1998 Jan; 9(1):13-9. PubMed ID: 9458238
[TBL] [Abstract][Full Text] [Related]
36. Insertion of the IL-2 gene decreases tumorigenicity of murine fibrosarcoma.
Kuśnierczyk H; Załecki P; Pajtasz-Piasecka E; Radzikowski C
Arch Immunol Ther Exp (Warsz); 1998; 46(4):259-65. PubMed ID: 9779293
[TBL] [Abstract][Full Text] [Related]
37. [Application of a tumor cell vaccine transfected with GM-CSF/IL-2 fusion gene for specific immunotherapy of hepatocellular carcinoma].
Guo C; Liu QG; Yang W; Yao YM
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Feb; 28(2):188-92. PubMed ID: 18250039
[TBL] [Abstract][Full Text] [Related]
38. Ablation of tumor cells in vivo by direct injection of HSV-thymidine kinase retroviral vector and ganciclovir therapy.
Howard BD; Kalthoff H; Fong TC
Ann N Y Acad Sci; 1999 Jun; 880():352-65. PubMed ID: 10415879
[TBL] [Abstract][Full Text] [Related]
39. Induction of antitumor immunity with combination of HER2/neu DNA vaccine and interleukin 2 gene-modified tumor vaccine.
Chen SA; Tsai MH; Wu FT; Hsiang A; Chen YL; Lei HY; Tzai TS; Leung HW; Jin YT; Hsieh CL; Hwang LH; Lai MD
Clin Cancer Res; 2000 Nov; 6(11):4381-8. PubMed ID: 11106257
[TBL] [Abstract][Full Text] [Related]
40. Recombinant Newcastle Disease Virus Encoding IL-12 and/or IL-2 as Potential Candidate for Hepatoma Carcinoma Therapy.
Ren G; Tian G; Liu Y; He J; Gao X; Yu Y; Liu X; Zhang X; Sun T; Liu S; Yin J; Li D
Technol Cancer Res Treat; 2016 Oct; 15(5):NP83-94. PubMed ID: 26303327
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
